- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Durvalumab Oleclumab
Total 729 results
-
MedImmune LLCCompletedStage III Non-small Cell Lung Cancer | UnresectableUnited States, Canada, Italy, Spain, France, Hong Kong, Portugal, Taiwan, Poland
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, France, Spain, Switzerland
-
MedImmune LLCCompletedSolid TumorsUnited States, Korea, Republic of, Australia
-
University Health Network, TorontoRecruiting
-
AstraZenecaRecruitingNon-Small Cell Lung CancerChina, Australia, Korea, Republic of, Canada, Poland, Spain, Vietnam, Germany, Brazil, Italy, Japan, Taiwan, Thailand, United States, United Kingdom, Portugal, Turkey, France, Peru, Colombia, Russian Federation, Ukraine
-
MedImmune LLCCompletedNSCLC | Resectable | Early-stageUnited States, Canada, Switzerland, Italy, France, Portugal, Spain
-
University Health Network, TorontoAstraZenecaWithdrawnRenal Cell Carcinoma | Non Small Cell Lung CancerCanada
-
University Health Network, TorontoAstraZenecaWithdrawnSquamous Cell Carcinoma of Head and Neck | Non-small Cell Lung Cancer | Pancreatic Ductal AdenocarcinomaCanada
-
Dana-Farber Cancer InstituteAstraZenecaCompletedMuscle Invasive Bladder CancerUnited States
-
Jules Bordet InstituteAstraZeneca; Institut CurieActive, not recruiting
-
MedImmune LLCWithdrawnMicrosatellite-stable Colorectal Cancer
-
AstraZenecaCompleted
-
Assistance Publique Hopitaux De MarseilleRecruitingNon-small Cell Lung CancerFrance
-
AstraZenecaCompletedProstate Cancer | Metastatic Castration-Resistant Prostate Cancer (mCRPC)United States
-
Jules Bordet InstituteAstraZenecaActive, not recruitingTriple Negative Breast CancerFrance, Belgium
-
MedImmune LLCTerminatedMetastatic Microsatellite-stable Colorectal CancerUnited States, Spain, France, Australia, Canada
-
AstraZenecaKappa SantéRecruiting
-
Yonsei UniversityRecruitingPotentially Resectable Stage II/IIIa NSCLCKorea, Republic of
-
Academic Thoracic Oncology Medical Investigators...AstraZenecaCompletedNon-Small Cell Lung Cancer NSCLCUnited States
-
Yonsei UniversityCompleted
-
NSABP Foundation IncCompletedRectal CancerUnited States
-
Hark Kyun KimRecruiting
-
Oslo University HospitalAstraZenecaActive, not recruitingCancer | NSCLC | Non Small Cell Lung Cancer | NSCLC, Stage III | Non Small Cell Lung Cancer Stage IIINorway, Finland, Lithuania, Estonia
-
Yonsei UniversityNot yet recruitingNon Small Cell Lung CancerKorea, Republic of
-
AstraZenecaCompleted
-
Assistance Publique - Hôpitaux de ParisAstraZenecaRecruitingBCLC A Hepatocellular Carcinoma Non-resectable and Not Amenable for RFAFrance
-
Biocity Biopharmaceutics Co., Ltd.Not yet recruitingHepatocellular CarcinomaChina
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; MedImmune LLCActive, not recruiting
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruiting
-
ETOP IBCSG Partners FoundationAstraZeneca AG SwitzerlandNot yet recruiting
-
AstraZenecaActive, not recruiting
-
Institut Claudius RegaudActive, not recruiting
-
AstraZenecaCompletedAdvanced Solid MalignanciesJapan
-
AstraZenecaRecruitingTriple Negative Breast NeoplasmsUnited States, Korea, Republic of, Canada, Taiwan, United Kingdom, Poland
-
Grupo Espanol Multidisciplinario del Cancer DigestivoAstraZeneca; Vall d'Hebron Institute of Oncology (VHIO)Recruiting
-
Institut Cancerologie de l'OuestAstraZenecaActive, not recruitingBone Metastases | Prostate Cancer Patients | Node; ProstateFrance
-
University Medical Center GroningenCambridge University Hospitals NHS Foundation TrustRecruitingEsophageal CancerNetherlands
-
Asan Medical CenterSamsung Medical CenterActive, not recruitingCholangiocarcinoma | Biliary Tract Neoplasms | Gallbladder CancerKorea, Republic of
-
John L. Villano, MD, PhDActive, not recruitingTumor, SolidUnited States
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingUrothelial CancerGermany, Switzerland
-
Yonsei UniversityCompletedMetastatic Breast CancerKorea, Republic of
-
Samsung Medical CenterActive, not recruitingHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
University of Texas Southwestern Medical CenterAstraZenecaActive, not recruitingNon Small Cell Lung Cancer | Lung Cancer Stage IIIUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Osteosarcoma | Refractory Osteosarcoma | Metastatic Osteosarcoma | Metastatic Angiosarcoma | Recurrent Dedifferentiated Liposarcoma | Metastatic Dedifferentiated Liposarcoma | Recurrent Angiosarcoma | Refractory Dedifferentiated LiposarcomaUnited States
-
AstraZenecaCompletedSmall Cell Lung Carcinoma Extensive DiseaseChina
-
Memorial Sloan Kettering Cancer CenterAstraZenecaCompletedAdenocarcinoma of the Bladder | Squamous Cell Carcinoma of the Bladder | Metastatic Bladder Cancer | Non-Transitional Cell Carcinoma of the Urothelial Tract | Small Cell of the BladderUnited States
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited States, Germany, Italy, United Kingdom, Canada, France, Korea, Republic of, Netherlands
-
MedPacto, Inc.AstraZenecaNot yet recruitingUrothelial Carcinoma Recurrent | Advanced Urothelial CarcinomaUnited States
-
Jonsson Comprehensive Cancer CenterAstraZenecaActive, not recruitingCarcinoma, Non-Small-Cell LungUnited States, Australia
-
Monika Joshi, MDAstraZenecaActive, not recruiting